Home » Newsletters » BioWorld Science

BioWorld Science

May 9, 2008

View Archived Issues

ProMetic BioSciences products show potential in pancreatic, prostate cancer

Merrimack Pharmaceuticals describes activity of anti-ErbB3 monoclonal antibody MM-121

Jerini presents preclinical and clinical data for JSM-6427 in AMD and other ocular conditions

Charlesson reports on novel small molecules as potential treatments for retinal diseases

Novel anti-CD19 antibody shows preclinical activity against lymphoma and leukemia

Oxytocin receptor agonist has anxiolytic-like effects in rodent models

Recent Wyeth patent reports novel agents for acute coronary syndrome

New agents for treating respiratory disorders disclosed in recent patent literature

NCI awards AlphaMed USD 750,000 grant for targeted melanoma therapy

Sernova concludes successful pre-IND meeting with FDA for Sertolin in diabetes

GenVec receives SBIR grant of USD 600,000 for respiratory syncytial virus vaccine

Opko acquires Vidus Ocular

FDA accepts Osteologix's IND application for NB-S101 for osteoporosis

Orexigen completes enrollment in NB-303 and NB-304 phase III clinical trials for Contrave

Memantine reduces hyperactivity in a rat mania model

Recent Japanese patent describes new treatment options for gout

Acucela files IND with the FDA to conduct phase I study for ACU-02

AstraZeneca submits sNDA for Seroquel XR for GAD

BMP receives SFDA acceptance for Enablex clinical trial

FDA Advisory Committee votes in favor of approval of fospropofol disodium

KeyNeurotek's phase I KN38-7271 study meets all endpoints

Vion initiates investigator-sponsored phase I/II Cloretazine trial

FDA approves Abilify for add-on treatment to lithium or valproate in bipolar I

Takeda successfully completes tender offer for Millennium

Taisho initiates phase I clinical trial of psychiatric drug candidate under partnership with Arena

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...